A Comparison Between Corifollitropin Alfa and Recombinant FSH for Follicular Recruitment in Women With Polycystic Ovaries Who Undergo IVM Treatment
Phase of Trial: Phase III
Latest Information Update: 21 May 2018
At a glance
- Drugs Corifollitropin alfa (Primary) ; Follitropin beta
- Indications Polycystic ovary syndrome
- Focus Therapeutic Use
- Acronyms Elonva_IVM
- 08 May 2018 Status changed from not yet recruiting to recruiting.
- 24 Oct 2017 Planned initiation date changed from 1 Sep 2017 to 1 Nov 2017.
- 08 Aug 2017 Planned initiation date changed from 1 Jul 2017 to 1 Sep 2017.